EGFR and Pleural effusion: Nevertheless, neither EGFR mutation testing nor full TKI response is easy to achieve, as former postulates availability of samples of biopsied/resected tumor tissue or pleural effusion and appropriate methodology, expertise and equipment [64], while later is undermined by intrinsic or acquired resistance to TKI that exists or develops in majority of patients [24–26].